Antibiotic Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

The American Journal of Gastroenterology - Tập 106 Số 4 - Trang 661-673 - 2011
Khurram J Khan1, Thomas Ullman2, Alexander C. Ford3, María T. Abreu4, Amir Abadir1, John K. Marshall1, Nicholas J. Talley5, Paul Moayyedi1,6
1McMaster University Medical Centre Hamilton, Ontario, Canada
2The Mount Sinai School of Medicine, New York, New York, USA
3Leeds Gastroenterology Institute, Leeds General Infirmary, Leeds, UK
4Miller School of Medicine, University of Miami, Miami, Florida, USA
5Faculty of Health, University of Newcastle, Callaghan, New South Wales, Australia
6Paul Moayyedi, McMaster University Medical Centre, Room 4W8E, 1200 Main Street West, Hamilton, Ontario, Canada. L8N 3Z5, E-mail: [email protected]

Tóm tắt

Từ khóa


Tài liệu tham khảo

Krisner, 1988, Historical aspects of inflammatory bowel disease., J Clin Gastroenterol, 10, 286, 10.1097/00004836-198806000-00012

Dalziel, 1913, Chronic interstitial enteritis., BMJ, 25, 1058

Sartor, 2005, Does Mycobacterium avium subspecies paratuberculosis cause Crohns disease?, Gut, 54, 896, 10.1136/gut.2004.055889

Abraham, 2009, Inflammatory bowel disease., N Engl J Med, 361, 2066, 10.1056/NEJMra0804647

Sellon, 1998, Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice., Infect Immun, 66, 5224, 10.1128/IAI.66.11.5224-5231.1998

Mantzaris, 1997, A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis., Am J Gastroenterol, 92, 454

Turunen, 1998, Long-term treatment of ulcerative colitis with ciprofloxacin: a prospective, double-blind, placebo-controlled study., Gastroenterology, 115, 1072, 10.1016/S0016-5085(98)70076-9

Borgaonkar, 2000, A meta-analysis of antimycobacterial therapy for Crohns disease., Am J Gastroenterol, 95, 725, 10.1111/j.1572-0241.2000.01842.x

Feller, 2010, Long-term antibiotic treatment for Crohns disease: systematic review and meta-analysis of placebo-controlled trials., Clin Infect Dis, 50, 473, 10.1086/649923

Rahimi, 2007, A meta-analysis of antibiotic therapy for active ulcerative colitis., Dig Dis Sci, 52, 2920, 10.1007/s10620-007-9760-1

DerSimonian, 1986, Meta-analysis in clinical trials., Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2

Higgins, 2003, Measuring inconsistency in meta-analyses., BMJ, 327, 557, 10.1136/bmj.327.7414.557

Egger, 1997, Bias in meta-analysis detected by a simple, graphical test., BMJ, 315, 629, 10.1136/bmj.315.7109.629

Prantera, 1994, Antimycobacterial therapy in Crohns disease: results of a controlled, double-blind trial with a multiple antibiotic regimen., Am J Gastroenterol, 89, 513

Selby, 2007, Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohns disease., Gastroenterology, 132, 2313, 10.1053/j.gastro.2007.03.031

Steinhart, 2002, Combined budesonide and antibiotic therapy for active Crohns disease: a randomized controlled trial., Gastroenterology, 123, 33, 10.1053/gast.2002.34225

Graham, 1995, Prolonged remission in Crohns disease following therapy for mycobacterium paratuberculosis infection., Gastroenterology, 108, A826, 10.1016/0016-5085(95)27612-2

Leiper, 2008, Clinical trial: randomized study of clarithromycin versus placebo in active Crohns disease., Aliment Pharmacol Ther, 27, 1233, 10.1111/j.1365-2036.2008.03661.x

Sutherland, 1991, Double blind, placebo controlled trial of metronidazole in Crohns disease., Gut, 32, 1071, 10.1136/gut.32.9.1071

Arnold, 2002, Preliminary study of ciprofloxacin in active Crohns disease., Inflamm Bowel Dis, 8, 10, 10.1097/00054725-200201000-00002

Afdhal, 1991, Controlled trial of antimycobacterial therapy in Crohns disease. Clofazimine versus placebo., Dig Dis Sci, 36, 449, 10.1007/BF01298873

Prantera, 2006, Antibiotic treatment of Crohns disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin., Aliment Pharmacol Ther, 23, 1117, 10.1111/j.1365-2036.2006.02879.x

Maeda, 2010, , The Topical Metronidazole in Perianal Crohns Study Group. Randomized clinical trial of metronidazole ointment versus placebo in perianal Crohns disease., Br J Surg, 97, 1340, 10.1002/bjs.7121

West, 2004, Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohns disease with infliximab: a double-blind placebo-controlled study., Aliment Pharmacol Ther, 20, 1329, 10.1111/j.1365-2036.2004.02247.x

Thia, 2009, Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohns disease: a randomized, double-blind, placebo-controlled pilot study., Inflamm Bowel Dis, 15, 17, 10.1002/ibd.20608

Mantzaris, 1994, Intravenous tobramycin and metronidazole as an adjunct to corticosteroids in acute, severe ulcerative colitis., Am J Gastroenterol, 89, 43

Ohkusa, 2005, Effectiveness of antibiotic combination therapy in patients with active ulcerative colitis: A randomized, controlled pilot trial with long-term follow-up., Scand J Gastroenterol, 40, 1334, 10.1080/00365520510023648

Ohkusa, 2010, Newly developed antibiotic combination therapy for ulcerative colitis: a double-blind placebo-controlled multicenter trial., Am J Gastroenterol, 105, 1820, 10.1038/ajg.2010.84

Mantzaris, 2001, A prospective randomized controlled trial of intravenous ciprofloxacin as an adjunct to corticosteroids in acute, severe ulcerative colitis., Scand J Gastroenterol, 36, 971, 10.1080/003655201750305503

Burke, 1990, The efficacy of tobramycin in the treatment of ulcerative colitis., Aliment Pharmacol Ther, 4, 123, 10.1111/j.1365-2036.1990.tb00456.x

Dickinson, 1985, Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis., Gut, 26, 1380, 10.1136/gut.26.12.1380

Gionchetti, 1999, Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: A double-blind, placebo-controlled trial., Dig Dis Sci, 44, 1220, 10.1023/A:1026648812439

Lobo, 1993, Oral tobramycin in ulcerative colitis: effect on maintenance of remission., Aliment Pharmacol Ther, 7, 155, 10.1111/j.1365-2036.1993.tb00084.x

Ambrose, 1985, Antibiotic therapy for treatment in relapse of intestinal Crohns disease. A prospective randomized study., Dis Colon Rectum, 28, 81, 10.1007/BF02552649

Chapman, 1986, Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis., Gut, 27, 1210, 10.1136/gut.27.10.1210

Goodgame, 2001, Randomized controlled trial of clarithromycin and ethambutol in the treatment of Crohns disease., Aliment Pharmacol Ther, 15, 1861, 10.1046/j.1365-2036.2001.01099.x

Swift, 1994, Controlled trial of anti-tuberculous chemotherapy for two years in Crohns disease., Gut, 35, 363, 10.1136/gut.35.3.363

Basilisco, 1989, Controlled trial of rifabutin in Crohns disease., Curr Ther Res, 46, 245

Kelleher, 1982, Preliminary trial of clofazimine in chronic inflammatory bowel disease., Gut, 23, A449

Rutgeerts, 2005, Ornidazole for prophylaxis of postoperative Crohns disease recurrence: a randomized, doubleblind, placebo-controlled trial., Gastroenterology, 128, 856, 10.1053/j.gastro.2005.01.010

Rutgeerts, 1995, Controlled trial of metronidazole treatment for prevention of Crohns recurrence after ileal resection., Gastroenterology, 108, 1617, 10.1016/0016-5085(95)90121-3

Shaffer, 1984, Controlled trial of rifampicin and ethambutol in Crohns disease., Gut, 25, 203, 10.1136/gut.25.2.203

Prantera, 1996, An antibiotic regimen for the treatment of active Crohns disease: a randomized, controlled trial of metronidazole plus ciprofloxacin., Am J Gastroenterol, 91, 328

Elliott, 1982, Sulphadoxine-pyrimethamine therapy in Crohns disease., Digestion, 23, 132, 10.1159/000198703

Pineton de Chambrun, 2008, Pathogenic agents in inflammatory bowel diseases., Curr Opin Gastroenterol, 24, 440, 10.1097/MOG.0b013e3283023be5

Feller, 2007, Mycobacterium avium subspecies paratuberculosis and Crohns disease: a systematic review and meta-analysis., Lancet Infect Dis, 7, 607, 10.1016/S1473-3099(07)70211-6

Pelosini, 2005, Rifaximin, a peculiar rifamycin derivative: established and potential clinical uses outside the gastrointestinal tract., Chemotherapy, 51, 122, 10.1159/000081999

Schoultz, 2000, Combined polymorphisms in genes encoding the inflammasome components NALP3 and CARD8 confer susceptibility to Crohns disease in Swedish men., Am J Gastroenterol, 104, 1180, 10.1038/ajg.2009.29

Schoepfer, 2009, Low Mannan-binding lectin serum levels are associated with complicated Crohns disease and reactivity to oligomannan (ASCA)., Am J Gastroenterol, 104, 2508, 10.1038/ajg.2009.315

Martinez, 2008, Unstable composition of the fecal microbiota in ulcerative colitis during clinical remission., Am J Gastroenterol, 103, 643, 10.1111/j.1572-0241.2007.01592.x

Juni, 2001, Assessing the quality of controlled clinical trials., BMJ, 323, 42, 10.1136/bmj.323.7303.42

Qin, 2010, A human gut microbial gene catalogue established by metagenomic sequencing., Nature, 464, 59, 10.1038/nature08821